Fluticasone Propionate Salmeterol
Clinical and economic outcomes for patients initiating fluticasone propionate/salmeterol combination therapy (250/50 mcg) versus anticholinergics in a comorbid COPD/depression population
... Methods: This retrospective, observational study used administrative claims of patients aged 40 years and older with COPD and comorbid depression/anxiety identified from January 1, 2004 through June 30, 2008. Patients ...
9
Fluticasone propionate-salmeterol versus inhaled corticosteroids plus montelukast: outcomes study in pediatric patients with asthma
... for fluticasone propionate-salmeterol, any ICS, or montelukast during the study ...for fluticasone propionate-salmeterol, ICS + montelukast, or long-acting beta-agonists during ...
10
Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial
... twice-daily fluticasone propionate/salmeterol (FP/SAL) (500/50 mcg) over 12 weeks in patients with COPD with dyspnoea and without exacerbations in the year prior to ...
12
The role of fluticasone propionate/salmeterol combination therapy in preventing exacerbations of COPD
... corticosteroid fluticasone propionate (250 µg) and the long-acting β 2 -agonist salmeterol (50 µg) in a single inhaler (250/50 µg) is an effective therapy option that has been shown to reduce the ...
14
Real-life use of fluticasone propionate/salmeterol in patients with chronic obstructive pulmonary disease: a French observational study
... with fluticasone propionate/salmeterol (500/ 50 μg) administered with a dry powder inhaler, pre- scribed by a general practitioner (GP) or ...
10
Efficacy and onset of action of mometasone furoate/formoterol and fluticasone propionate/salmeterol combination treatment in subjects with persistent asthma
... The most recent ICS/LABA combination therapy indi- cated for the treatment of persistent asthma is mometa- sone furoate/formoterol delivered via metered-dose inhaler (MF/F-MDI; Dulera ® /Zenhale ® , Schering Cor- ...
9
Asthma control using fluticasone propionate/salmeterol in Asian and non-Asian populations: a post hoc analysis of the GOAL study
... noted, however, that the ACQ measured asthma control over a recall period of only 7 days, whereas control in the GOAL study was measured over 8-week periods. In another study, the efficacy of a different ICS/LABA com- ...
12
Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease
... Additionally, a time-to-event proportional hazard analysis of 43,792 patients (the “risk population”) indicated that those receiving ipratropium or tiotropium for initial m[r] ...
10
Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation
... In this study, patients with COPD received double-blind treatment, commencing within 14 days following an initial exacerbation, with either an ICS/LABA combination of flu- ticasone propionate/salmeterol ...
12
Observational study on the impact of initiating tiotropium alone versus tiotropium with fluticasone propionate/salmeterol combination therapy on outcomes and costs in chronic obstructive pulmonary disease
... Background: This retrospective cohort study compared the risks of exacerbations and COPD-related healthcare costs between patients with chronic obstructive pulmonary disease (COPD) initi[r] ...
9
Cost-effectiveness of combination fluticasone propionate–salmeterol 250/50 μg versus salmeterol in severe COPD patients
... Results from our analyses are only relevant to severe COPD patients and for patients using FSC and salmeterol. Other COPD medications such as tiotropium were not included as therapeutic agents in the trials. A ...
9
Does device matter for inhaled therapies in advanced chronic obstructive pulmonary disease (COPD)? A comparative trial of two devices
... SFC: fluticasone propionate/salmeterol xinafoate; SWSLHD: South West Sydney Local Health District; HREC: Human Research Ethics Committee; SGRQ: Saint George Respiratory Questionnaire; 6MWT: 6 min ...
6
A Case of Atrial Fibrillation Induced by Inhaled Fluticasone Propionate
... for 5 days of anticoagulation with 4000 IU of enoxaparin for thromboembolic pro- phylaxis. After 1 week of hospitalization, the boy was discharged, and fluticasone propionate was removed from his drug regimen. ...
7
Effect of Salmeterol-Fluticasone Combination and Tiotropium on Clinical and Physiological Improvement of Bronchial Anthracofibrosis: a Double Blind Randomized, Cross Over, Placebo Controlled, Clinical Trial
... the salmeterol- fluticasone in our anthracofibrosis subjects, especially in those with sputum and wheezing (41 and 31% improvement, respectively) (Table 1), but the statistical analysis did not show ...
9
Indacaterol: a comprehensive review
... five minutes) and longer (ie, 24 hours) than that with traditional LABA, with the same 12-hour effect as salmeterol and formoterol, both of which require twice-daily administration. This is why indacaterol has ...
11
Spotlight on fluticasone furoate/vilanterol trifenatate for the once-daily treatment of asthma: design, development and place in therapy
... Abstract: The use of inhaled corticosteroids (ICSs) plays a key role in the treatment of asthmatic patients, and international guidelines have designated ICSs as an early maintenance therapy in controlling asthma ...
14
Effect of salmeterol/fluticasone combination on the dynamic changes of lung mechanics in mechanically ventilated COPD patients: a prospective pilot study
... with salmeterol/fluticasone ...with salmeterol/ fluticasone, and in the remaining eight patients, the mean Rrs change from baseline was ...
8
Changing patterns in long-acting bronchodilator trials in chronic obstructive pulmonary disease
... 19. Rennard SI, Donohue JF, Bateman ED, Gross NJ, Garcia Gil E, Caracta C. Efficacy and safety of the novel, long-acting antimuscarinic, aclidinium bromide, in COPD patients in a Phase III study: ACCLAIM/ COPD II ...
11
Fluticasone propionate/formoterol for COPD management: a randomized controlled trial
... inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel ran- domized controlled ...
11
Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function
... of fluticasone propionate or budesonide on percent phagocytosis of Haemophilus influenzae and Streptococcus pneumoniae by COPD ...with fluticasone propionate ( ) or budesonide () at indicated ...
15